TY - JOUR
T1 - Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units
T2 - a multi-center experience
AU - Mohanty, Sanghamitra
AU - Lakkireddy, Dhanunjaya
AU - Trivedi, Chintan
AU - MacDonald, Bryan
AU - Quintero Mayedo, Angel
AU - Della Rocca, Domenico G.
AU - Atkins, Donita
AU - Park, Peter
AU - Shah, Alap
AU - Gopinathannair, Rakesh
AU - Al-Ahmad, Amin
AU - Burkhardt, John D.
AU - Gallinghouse, G. J.
AU - Bassiouny, Mohamed
AU - Di Biase, Luigi
AU - Kessler, David
AU - Tschopp, David
AU - Coffeen, Paul
AU - Horton, Rodney
AU - Canby, Robert
AU - Natale, Andrea
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/10
Y1 - 2021/10
N2 - Background: As the coronavirus cases continue to surge, the urgent need for universal testing to identify positive cases for effective containment of this highly contagious pandemic has become the center of attention worldwide. However, in spite of extensive discussions, very few places have even attempted to implement it. We evaluated the efficacy of widespread testing in creating a safe workplace in our electrophysiology (EP) community. Furthermore, we assessed the new infection rate in patients undergoing EP procedure, to see if identification and exclusion of positive cases facilitated establishment of a risk-free operating environment. Methods: Viral-RNA and serology tests were conducted in 1670 asymptomatic subjects including patients and their caregivers and staff in our EP units along with the Emergency Medical Service (EMS) staff. Results: Of 1670, 758 (45.4%) were patients and the remaining 912 were caregivers, EMS staff, and staff from EP clinic and lab. Viral-RNA test revealed 64 (3.8%) positives in the population. A significant increase in positivity rate was observed from April to June 2020 (p = 0.02). Procedures of positive cases (n = 31) were postponed until they tested negative at retesting. Staff testing positive (n = 33) were retested before going back to work after 2 weeks. Because of suspected exposure, 67 staff were retested and source was traced. No new infections were reported in patients during or within 2 weeks after the hospital-stay. Conclusions: Universal testing to identify positive cases was helpful in creating and maintaining a safe working environment without exposing patients and staff to new infections in the EP units. Trial registration: Trial Registration Number: clinicaltrials.gov: NCT04352764.
AB - Background: As the coronavirus cases continue to surge, the urgent need for universal testing to identify positive cases for effective containment of this highly contagious pandemic has become the center of attention worldwide. However, in spite of extensive discussions, very few places have even attempted to implement it. We evaluated the efficacy of widespread testing in creating a safe workplace in our electrophysiology (EP) community. Furthermore, we assessed the new infection rate in patients undergoing EP procedure, to see if identification and exclusion of positive cases facilitated establishment of a risk-free operating environment. Methods: Viral-RNA and serology tests were conducted in 1670 asymptomatic subjects including patients and their caregivers and staff in our EP units along with the Emergency Medical Service (EMS) staff. Results: Of 1670, 758 (45.4%) were patients and the remaining 912 were caregivers, EMS staff, and staff from EP clinic and lab. Viral-RNA test revealed 64 (3.8%) positives in the population. A significant increase in positivity rate was observed from April to June 2020 (p = 0.02). Procedures of positive cases (n = 31) were postponed until they tested negative at retesting. Staff testing positive (n = 33) were retested before going back to work after 2 weeks. Because of suspected exposure, 67 staff were retested and source was traced. No new infections were reported in patients during or within 2 weeks after the hospital-stay. Conclusions: Universal testing to identify positive cases was helpful in creating and maintaining a safe working environment without exposing patients and staff to new infections in the EP units. Trial registration: Trial Registration Number: clinicaltrials.gov: NCT04352764.
KW - Asymptomatic
KW - COVID-19
KW - Electrophysiology
KW - Serology
KW - Universal testing
KW - Viral-RNA
UR - http://www.scopus.com/inward/record.url?scp=85091800423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091800423&partnerID=8YFLogxK
U2 - 10.1007/s10840-020-00886-9
DO - 10.1007/s10840-020-00886-9
M3 - Article
C2 - 33006086
AN - SCOPUS:85091800423
SN - 1383-875X
VL - 62
SP - 171
EP - 176
JO - Journal of Interventional Cardiac Electrophysiology
JF - Journal of Interventional Cardiac Electrophysiology
IS - 1
ER -